Sara Öberg

Sara Öberg is a Principal Researcher at the Karolinska Institutet's Department of Medical Epidemiology and Biostatistics, with adjunct appointments at Harvard Chan School of Public Health. She focuses on the causes and consequences of reproductive challenges, using collaborative research, family designs, and advanced statistical methods to explore maternal and offspring health.

Her research spans pre-conception through postnatal outcomes, examining long-term effects of assisted reproductive techniques (ART), prescribed drug safety during pregnancy, and causal inference using sibling comparisons. She co-leads the UppStART study and contributes to international collaborations like the LIFT Study.

Current trends in her publications emphasize multidisciplinary approaches to reproductive health, including epigenetics, cardiovascular risks post-ART, and neurodevelopmental impacts of maternal medication use. Her methodological work focuses on refining sibling comparison designs and genetic epidemiology techniques.

Scientific awards and funding acknowledgments include support from

• National Institutes of Health
• Swedish Research Council
• Fulbright
• Karolinska Institutet

Advising roles span PhD candidates at Karolinska Institutet, Charité Universitätsmedizin Berlin, and Indiana University. She has contributed to epidemiological training as an instructor at Harvard Chan School of Public Health.

Grants cover topics like social networks in fertility differentials, opioid impact on perinatal outcomes, and ART's long-term health consequences. Her team includes research specialists and PhD students across multiple institutions.